Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 21:57:29 UTC |
---|
Update Date | 2021-09-26 23:16:55 UTC |
---|
HMDB ID | HMDB0259400 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Ulixertinib |
---|
Description | 4-{5-chloro-2-[(propan-2-yl)amino]pyridin-4-yl}-N-[1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide belongs to the class of organic compounds known as 2-heteroaryl carboxamides. 2-heteroaryl carboxamides are compounds containing a heteroaromatic ring that carries a carboxamide group. Based on a literature review very few articles have been published on 4-{5-chloro-2-[(propan-2-yl)amino]pyridin-4-yl}-N-[1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). Ulixertinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Ulixertinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC(C)NC1=NC=C(Cl)C(=C1)C1=CNC(=C1)C(=O)NC(CO)C1=CC(Cl)=CC=C1 InChI=1S/C21H22Cl2N4O2/c1-12(2)26-20-8-16(17(23)10-25-20)14-7-18(24-9-14)21(29)27-19(11-28)13-4-3-5-15(22)6-13/h3-10,12,19,24,28H,11H2,1-2H3,(H,25,26)(H,27,29) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C21H22Cl2N4O2 |
---|
Average Molecular Weight | 433.33 |
---|
Monoisotopic Molecular Weight | 432.1119814 |
---|
IUPAC Name | 4-{5-chloro-2-[(propan-2-yl)amino]pyridin-4-yl}-N-[1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide |
---|
Traditional Name | 4-[5-chloro-2-(isopropylamino)pyridin-4-yl]-N-[1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(C)NC1=NC=C(Cl)C(=C1)C1=CNC(=C1)C(=O)NC(CO)C1=CC(Cl)=CC=C1 |
---|
InChI Identifier | InChI=1S/C21H22Cl2N4O2/c1-12(2)26-20-8-16(17(23)10-25-20)14-7-18(24-9-14)21(29)27-19(11-28)13-4-3-5-15(22)6-13/h3-10,12,19,24,28H,11H2,1-2H3,(H,25,26)(H,27,29) |
---|
InChI Key | KSERXGMCDHOLSS-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 2-heteroaryl carboxamides. 2-Heteroaryl carboxamides are compounds containing a heteroaromatic ring that carries a carboxamide group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Carboxylic acid derivatives |
---|
Direct Parent | 2-heteroaryl carboxamides |
---|
Alternative Parents | |
---|
Substituents | - 2-heteroaryl carboxamide
- Pyrrole-2-carboxamide
- Pyrrole-2-carboxylic acid or derivatives
- Aminopyridine
- Chlorobenzene
- Halobenzene
- Secondary aliphatic/aromatic amine
- Imidolactam
- Benzenoid
- Substituted pyrrole
- Aryl chloride
- Pyridine
- Aryl halide
- Monocyclic benzene moiety
- Heteroaromatic compound
- Pyrrole
- Secondary carboxylic acid amide
- Amino acid or derivatives
- Organoheterocyclic compound
- Secondary amine
- Azacycle
- Organic oxide
- Organochloride
- Organohalogen compound
- Organonitrogen compound
- Amine
- Organooxygen compound
- Primary alcohol
- Organic nitrogen compound
- Organic oxygen compound
- Alcohol
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 202.869 | 30932474 | DeepCCS | [M-H]- | 200.511 | 30932474 | DeepCCS | [M-2H]- | 233.831 | 30932474 | DeepCCS | [M+Na]+ | 209.059 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Ulixertinib,2TMS,isomer #1 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)NC(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3430.8 | Semi standard non polar | 33892256 | Ulixertinib,2TMS,isomer #1 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)NC(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3424.4 | Standard non polar | 33892256 | Ulixertinib,2TMS,isomer #1 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)NC(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C | 4639.5 | Standard polar | 33892256 | Ulixertinib,2TMS,isomer #2 | CC(C)NC1=CC(C2=CN([Si](C)(C)C)C(C(=O)NC(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1 | 3579.9 | Semi standard non polar | 33892256 | Ulixertinib,2TMS,isomer #2 | CC(C)NC1=CC(C2=CN([Si](C)(C)C)C(C(=O)NC(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1 | 3460.0 | Standard non polar | 33892256 | Ulixertinib,2TMS,isomer #2 | CC(C)NC1=CC(C2=CN([Si](C)(C)C)C(C(=O)NC(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1 | 4476.4 | Standard polar | 33892256 | Ulixertinib,2TMS,isomer #3 | CC(C)NC1=CC(C2=C[NH]C(C(=O)N(C(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1 | 3489.2 | Semi standard non polar | 33892256 | Ulixertinib,2TMS,isomer #3 | CC(C)NC1=CC(C2=C[NH]C(C(=O)N(C(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1 | 3453.2 | Standard non polar | 33892256 | Ulixertinib,2TMS,isomer #3 | CC(C)NC1=CC(C2=C[NH]C(C(=O)N(C(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1 | 4424.1 | Standard polar | 33892256 | Ulixertinib,2TMS,isomer #4 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C)C(C(=O)NC(CO)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3517.0 | Semi standard non polar | 33892256 | Ulixertinib,2TMS,isomer #4 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C)C(C(=O)NC(CO)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3453.9 | Standard non polar | 33892256 | Ulixertinib,2TMS,isomer #4 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C)C(C(=O)NC(CO)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C | 4500.6 | Standard polar | 33892256 | Ulixertinib,2TMS,isomer #5 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3393.5 | Semi standard non polar | 33892256 | Ulixertinib,2TMS,isomer #5 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3416.6 | Standard non polar | 33892256 | Ulixertinib,2TMS,isomer #5 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C | 4430.9 | Standard polar | 33892256 | Ulixertinib,2TMS,isomer #6 | CC(C)NC1=CC(C2=CN([Si](C)(C)C)C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1 | 3545.3 | Semi standard non polar | 33892256 | Ulixertinib,2TMS,isomer #6 | CC(C)NC1=CC(C2=CN([Si](C)(C)C)C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1 | 3356.0 | Standard non polar | 33892256 | Ulixertinib,2TMS,isomer #6 | CC(C)NC1=CC(C2=CN([Si](C)(C)C)C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1 | 4443.9 | Standard polar | 33892256 | Ulixertinib,3TMS,isomer #1 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C)C(C(=O)NC(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3483.7 | Semi standard non polar | 33892256 | Ulixertinib,3TMS,isomer #1 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C)C(C(=O)NC(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3484.6 | Standard non polar | 33892256 | Ulixertinib,3TMS,isomer #1 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C)C(C(=O)NC(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C | 4182.2 | Standard polar | 33892256 | Ulixertinib,3TMS,isomer #2 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)N(C(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3408.8 | Semi standard non polar | 33892256 | Ulixertinib,3TMS,isomer #2 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)N(C(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3461.6 | Standard non polar | 33892256 | Ulixertinib,3TMS,isomer #2 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)N(C(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C | 4111.9 | Standard polar | 33892256 | Ulixertinib,3TMS,isomer #3 | CC(C)NC1=CC(C2=CN([Si](C)(C)C)C(C(=O)N(C(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1 | 3525.8 | Semi standard non polar | 33892256 | Ulixertinib,3TMS,isomer #3 | CC(C)NC1=CC(C2=CN([Si](C)(C)C)C(C(=O)N(C(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1 | 3410.7 | Standard non polar | 33892256 | Ulixertinib,3TMS,isomer #3 | CC(C)NC1=CC(C2=CN([Si](C)(C)C)C(C(=O)N(C(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1 | 4150.5 | Standard polar | 33892256 | Ulixertinib,3TMS,isomer #4 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C)C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3448.5 | Semi standard non polar | 33892256 | Ulixertinib,3TMS,isomer #4 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C)C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3382.7 | Standard non polar | 33892256 | Ulixertinib,3TMS,isomer #4 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C)C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C | 4164.4 | Standard polar | 33892256 | Ulixertinib,4TMS,isomer #1 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C)C(C(=O)N(C(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3495.6 | Semi standard non polar | 33892256 | Ulixertinib,4TMS,isomer #1 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C)C(C(=O)N(C(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3425.3 | Standard non polar | 33892256 | Ulixertinib,4TMS,isomer #1 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C)C(C(=O)N(C(CO[Si](C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C | 3910.3 | Standard polar | 33892256 | Ulixertinib,2TBDMS,isomer #1 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)NC(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 3845.5 | Semi standard non polar | 33892256 | Ulixertinib,2TBDMS,isomer #1 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)NC(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 3868.0 | Standard non polar | 33892256 | Ulixertinib,2TBDMS,isomer #1 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)NC(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4667.4 | Standard polar | 33892256 | Ulixertinib,2TBDMS,isomer #2 | CC(C)NC1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)NC(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1 | 3974.6 | Semi standard non polar | 33892256 | Ulixertinib,2TBDMS,isomer #2 | CC(C)NC1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)NC(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1 | 3837.0 | Standard non polar | 33892256 | Ulixertinib,2TBDMS,isomer #2 | CC(C)NC1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)NC(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1 | 4512.7 | Standard polar | 33892256 | Ulixertinib,2TBDMS,isomer #3 | CC(C)NC1=CC(C2=C[NH]C(C(=O)N(C(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1 | 3873.4 | Semi standard non polar | 33892256 | Ulixertinib,2TBDMS,isomer #3 | CC(C)NC1=CC(C2=C[NH]C(C(=O)N(C(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1 | 3881.9 | Standard non polar | 33892256 | Ulixertinib,2TBDMS,isomer #3 | CC(C)NC1=CC(C2=C[NH]C(C(=O)N(C(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1 | 4478.6 | Standard polar | 33892256 | Ulixertinib,2TBDMS,isomer #4 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)NC(CO)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 3935.2 | Semi standard non polar | 33892256 | Ulixertinib,2TBDMS,isomer #4 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)NC(CO)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 3873.6 | Standard non polar | 33892256 | Ulixertinib,2TBDMS,isomer #4 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)NC(CO)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4506.7 | Standard polar | 33892256 | Ulixertinib,2TBDMS,isomer #5 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 3795.5 | Semi standard non polar | 33892256 | Ulixertinib,2TBDMS,isomer #5 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 3874.8 | Standard non polar | 33892256 | Ulixertinib,2TBDMS,isomer #5 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4457.0 | Standard polar | 33892256 | Ulixertinib,2TBDMS,isomer #6 | CC(C)NC1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1 | 3946.8 | Semi standard non polar | 33892256 | Ulixertinib,2TBDMS,isomer #6 | CC(C)NC1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1 | 3774.3 | Standard non polar | 33892256 | Ulixertinib,2TBDMS,isomer #6 | CC(C)NC1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1 | 4472.6 | Standard polar | 33892256 | Ulixertinib,3TBDMS,isomer #1 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)NC(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4079.8 | Semi standard non polar | 33892256 | Ulixertinib,3TBDMS,isomer #1 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)NC(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4093.8 | Standard non polar | 33892256 | Ulixertinib,3TBDMS,isomer #1 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)NC(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4306.6 | Standard polar | 33892256 | Ulixertinib,3TBDMS,isomer #2 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)N(C(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 3953.8 | Semi standard non polar | 33892256 | Ulixertinib,3TBDMS,isomer #2 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)N(C(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4122.9 | Standard non polar | 33892256 | Ulixertinib,3TBDMS,isomer #2 | CC(C)N(C1=CC(C2=C[NH]C(C(=O)N(C(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4237.7 | Standard polar | 33892256 | Ulixertinib,3TBDMS,isomer #3 | CC(C)NC1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)N(C(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1 | 4105.7 | Semi standard non polar | 33892256 | Ulixertinib,3TBDMS,isomer #3 | CC(C)NC1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)N(C(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1 | 4028.0 | Standard non polar | 33892256 | Ulixertinib,3TBDMS,isomer #3 | CC(C)NC1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)N(C(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1 | 4285.0 | Standard polar | 33892256 | Ulixertinib,3TBDMS,isomer #4 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4047.2 | Semi standard non polar | 33892256 | Ulixertinib,3TBDMS,isomer #4 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4030.0 | Standard non polar | 33892256 | Ulixertinib,3TBDMS,isomer #4 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)N(C(CO)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4269.6 | Standard polar | 33892256 | Ulixertinib,4TBDMS,isomer #1 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)N(C(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4236.3 | Semi standard non polar | 33892256 | Ulixertinib,4TBDMS,isomer #1 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)N(C(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4248.4 | Standard non polar | 33892256 | Ulixertinib,4TBDMS,isomer #1 | CC(C)N(C1=CC(C2=CN([Si](C)(C)C(C)(C)C)C(C(=O)N(C(CO[Si](C)(C)C(C)(C)C)C3=CC=CC(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2)=C(Cl)C=N1)[Si](C)(C)C(C)(C)C | 4124.5 | Standard polar | 33892256 |
|
---|